CHERNETT JOREY purchased 0.1% of their position (12K shares) of STARLING ONCOLOGY, INC. on the open market
Open‑market purchase worth $78.5K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 8/17/2026ACC: 0000921895-26-002203
+11.90K
Net shares
Net buyer
$78.5K
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
12K acquired · 100.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+12K
Price / share
$6.54
Trade value
$78.48K
% of position
0.1%
8/14/2026
10.65M→10.66M
Total
Net shares
+12K
Net value
$78.48K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/14/2026 | P · Purchase | +12K | $6.54 | $78.48K | 0.1% | 10.65M | 10.66M |
| Total | +12K | $78.48K | ||||||
Derivative Transactions1
Call Option (STLN 19FEB27 $9C)
Direct
Converts to
Common Stock
10K shares
Shares
−100.00
Strike price
9
Held after
0.00
Exercisable
—
8/13/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Call Option (STLN 19FEB27 $9C) Direct | Common Stock10K shares | 8/13/2026 | S · Sale | −100.00 | 9 | — | 0.00 |